115 related articles for article (PubMed ID: 29949032)
1. Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study.
Jecmenica-Lukic MV; Pekmezovic TD; Petrovic IN; Dragasevic NT; Kostić VS
Acta Neurol Belg; 2018 Dec; 118(4):589-595. PubMed ID: 29949032
[TBL] [Abstract][Full Text] [Related]
2. Natural history of multiple system atrophy in the USA: a prospective cohort study.
Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
[TBL] [Abstract][Full Text] [Related]
3. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.
Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H
Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.
Damon-Perrière N; Foubert-Samier A; De Cock VC; Gerdelat-Mas A; Debs R; Pavy-Le Traon A; Senard JM; Rascol O; Tison F; Meissner WG
Parkinsonism Relat Disord; 2012 Jun; 18(5):612-5. PubMed ID: 22236582
[TBL] [Abstract][Full Text] [Related]
6. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.
Du JJ; Wang T; Huang P; Cui S; Gao C; Lin Y; Fu R; Zhou H; Chen S
Brain Behav; 2018 Dec; 8(12):e01135. PubMed ID: 30378279
[TBL] [Abstract][Full Text] [Related]
8. Assessment of quality of life with the multiple system atrophy health-related quality of life scale.
Meissner WG; Foubert-Samier A; Dupouy S; Gerdelat-Mas A; Debs R; Marquant F; De Cock VC; Rascol O; Tison F; Pavy-Le Traon A
Mov Disord; 2012 Oct; 27(12):1574-7. PubMed ID: 23033055
[TBL] [Abstract][Full Text] [Related]
9. Frontal lobe function, behavioral changes and quality of life in patients with multiple system atrophy.
Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H
Restor Neurol Neurosci; 2019; 37(1):11-19. PubMed ID: 30741706
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy.
Barcelos LB; Saad F; Giacominelli C; Saba RA; de Carvalho Aguiar PM; Silva SMA; Borges V; Bertolucci PHF; Ferraz HB
Clin Neurol Neurosurg; 2018 Jan; 164():121-126. PubMed ID: 29223069
[TBL] [Abstract][Full Text] [Related]
11. Possible multiple system atrophy with predominant parkinsonism in a patient with chronic schizophrenia: a case report.
Komatsu H; Kato M; Kinpara T; Ono T; Kakuto Y
BMC Psychiatry; 2018 May; 18(1):141. PubMed ID: 29783976
[TBL] [Abstract][Full Text] [Related]
12. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in multiple system atrophy.
Schrag A; Geser F; Stampfer-Kountchev M; Seppi K; Sawires M; Köllensperger M; Scherfler C; Quinn N; Pellecchia MT; Barone P; Del Sorbo F; Albanese A; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Nilsson CF; Widner H; Lindvall O; Giladi N; Gurevich T; Daniels C; Deuschl G; Coelho M; Sampaio C; Abele M; Klockgether T; Schimke N; Eggert KM; Oertel W; Djaldetti R; Colosimo C; Meco G; Poewe W; Wenning GK;
Mov Disord; 2006 Jun; 21(6):809-15. PubMed ID: 16502399
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with progressive supranuclear palsy: one-year follow-up.
Pekmezović T; Ječmenica-Lukić M; Petrović I; Špica V; Tomić A; Kostić VS
J Neurol; 2015 Sep; 262(9):2042-8. PubMed ID: 26070289
[TBL] [Abstract][Full Text] [Related]
15. The natural history of multiple system atrophy: a prospective European cohort study.
Wenning GK; Geser F; Krismer F; Seppi K; Duerr S; Boesch S; Köllensperger M; Goebel G; Pfeiffer KP; Barone P; Pellecchia MT; Quinn NP; Koukouni V; Fowler CJ; Schrag A; Mathias CJ; Giladi N; Gurevich T; Dupont E; Ostergaard K; Nilsson CF; Widner H; Oertel W; Eggert KM; Albanese A; del Sorbo F; Tolosa E; Cardozo A; Deuschl G; Hellriegel H; Klockgether T; Dodel R; Sampaio C; Coelho M; Djaldetti R; Melamed E; Gasser T; Kamm C; Meco G; Colosimo C; Rascol O; Meissner WG; Tison F; Poewe W;
Lancet Neurol; 2013 Mar; 12(3):264-74. PubMed ID: 23391524
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.
Winter Y; Spottke AE; Stamelou M; Cabanel N; Eggert K; Höglinger GU; Sixel-Doering F; Herting B; Klockgether T; Reichmann H; Oertel WH; Dodel R
Neurodegener Dis; 2011; 8(6):438-46. PubMed ID: 21576919
[TBL] [Abstract][Full Text] [Related]
17. Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.
Wang Y; Shen Y; Xiong KP; He PC; Mao CJ; Li J; Wang FY; Wang YL; Huang JY; Liu CF
Chin Med J (Engl); 2017 Mar; 130(6):684-690. PubMed ID: 28303851
[TBL] [Abstract][Full Text] [Related]
18. Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study.
Foubert-Samier A; Pavy-Le Traon A; Guillet F; Le-Goff M; Helmer C; Tison F; Rascol O; Proust-Lima C; Meissner WG
Neurobiol Dis; 2020 Jun; 139():104813. PubMed ID: 32087288
[TBL] [Abstract][Full Text] [Related]
19. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
[TBL] [Abstract][Full Text] [Related]
20. Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology.
Terao Y; Fukuda H; Tokushige S; Inomata-Terada S; Yugeta A; Hamada M; Ichikawa Y; Hanajima R; Ugawa Y
Clin Neurophysiol; 2016 Feb; 127(2):1491-1502. PubMed ID: 26350408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]